Zeria Pharmaceutical
Zeria is a Tokyo pharmaceutical company founded in 1955, strongest in gastroenterology, that sponsors phase 3 cancer trials in Japan.
Overview
Zeria Pharmaceutical Co., Ltd., based in Chūō, Tokyo, and founded in 1955, makes prescription and consumer medicines with a focus on gastrointestinal disease, including bowel preparations used before colonoscopy, and has acted as lead sponsor of phase 3 trials in cancer-related settings registered on ClinicalTrials.gov.
Similar pages
not linked directly; found by shared links- CompanyNorgine
Shares Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), Pivotal (registrational) trial, Clinical trial, Colorectal cancer and the tag ctgov-sponsor.
- CompanyAeterna Zentaris
Shares Pivotal (registrational) trial, Clinical trial, Colorectal cancer and the tag ctgov-sponsor.
- CompanyCancer Prevention Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial, Colorectal cancer and the tag ctgov-sponsor.
- CompanyCSL Limited
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyD3 Bio (Wuxi)
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyDong-A ST
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyEndo (now Keenova Therapeutics and Par Health)
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyEurofarma
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.